Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul 12:2022:7073158.
doi: 10.1155/2022/7073158. eCollection 2022.

A Novel Missense Mutation of Arginine Vasopressin Receptor 2 in a Chinese Family with Congenital Nephrogenic Diabetes Insipidus: X-Chromosome Inactivation in Female CNDI Patients with Heterozygote 814A>G Mutation

Affiliations

A Novel Missense Mutation of Arginine Vasopressin Receptor 2 in a Chinese Family with Congenital Nephrogenic Diabetes Insipidus: X-Chromosome Inactivation in Female CNDI Patients with Heterozygote 814A>G Mutation

Li Zang et al. Biomed Res Int. .

Retraction in

Abstract

Background: To identify novel clinical phenotypic signatures of congenital nephrogenic diabetes insipidus (CNDI).

Methods: A Chinese family with CNDI was recruited for participation in this study. The proband and one of his uncles suffered from polydipsia and polyuria since infancy. The results of clinical testing indicated the diagnosis of CNDI. 10 family members had similar symptoms but did not seek medical advice. Genetic testing of mutations in the coding region of the aquaporin 2 (AQP2) gene and the arginine vasopressin receptor 2 (AVPR2) gene were carried out in 11 family members. Somatic DNA from 5 female family members was used to test for methylation of polymorphic CAG repeats in the human androgen receptor (AR) gene, as an index for X-chromosome inactivation pattern (XCIP).

Results: AQP2 gene mutations were not found in any family members, but a novel missense mutation (814th base A>G) in exon 2 of the AVPR2 gene was identified in 10 individuals. This mutation leads to a Met 272 Val (GAT-GGT) amino acid substitution. Skewed X-chromosome inactivation patterns of the normal X allele were observed in 4 females with the AVPR2 gene mutation and symptoms of diabetes insipidus, but not in an asymptomatic female with the AVPR2 gene mutation.

Conclusions: Met 272 Val mutation of the AVPR2 gene was identified as a novel genetic risk factor for CDNI. The clinical NDI phenotype of female carriers with heterozygous AVPR2 mutation may be caused by X-chromosome inactivation induced by dominant methylation of the normal allele of AVPR2 gene.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

Figures

Figure 1
Figure 1
The pedigree of the Chinese family with congenital nephrogenic diabetes insipidus. Solid symbols denote the affected individuals. The arrow indicates the proband.
Figure 2
Figure 2
The imaging feature of the proband. (a) Pituitary MRI showed normal anterior and posterior pituitary. (b) Urinary system CT scan showed bilateral ureterectasis and hydronephrosis combined with right kidney atrophy.
Figure 3
Figure 3
Sequence analysis of the 2nd and 3rd exons in AVPR2 gene. (a, b) sequencing in the 814th base of 2nd exon, A was substitute of G which resulted a Met 272 Val (GAT-GGT) amino acid substitution. A was hemizygous mutation in the male subjects, B was heterozygous mutation in the female subjects. (c, d) sequencing in the 927th base of 3rd exon, A was substitute of G which suggested a silent mutation Leu 309 Leu. C was hemizygous mutation in the male subjects; D was heterozygous mutation in the female subjects.

Similar articles

Cited by

References

    1. Yoo T. H., Ryu D. R., Song Y. S., et al. Congenital nephrogenic diabetes insipidus presented with bilateral hydronephrosis: genetic analysis of V2R gene mutations. Yonsei Medical Journal . 2006;47(1):126–130. doi: 10.3349/ymj.2006.47.1.126. - DOI - PMC - PubMed
    1. Morello J. P., Bichet D. G. Nephrogenic diabetes insipidus. Annual Review of Physiology . 2001;63(1):607–630. doi: 10.1146/annurev.physiol.63.1.607. - DOI - PubMed
    1. Bockenhauer D., Bichet D. G. Nephrogenic diabetes insipidus. Current Opinion in Pediatrics . 2017;29(2):199–205. doi: 10.1097/MOP.0000000000000473. - DOI - PubMed
    1. Çelebi Tayfur A., Karaduman T., Özcan Türkmen M., et al. A novel mutation in the AVPR2 gene causing congenital nephrogenic diabetes insipidus. Journal of Clinical Research in Pediatric Endocrinology . 2018;10(4):350–356. doi: 10.4274/jcrpe.0097. - DOI - PMC - PubMed
    1. Rugpolmuang R., Deeb A., Hassan Y., Deekajorndech T., Shotelersuk V., Sahakitrungruang T. Novel AQP2 mutation causing congenital nephrogenic diabetes insipidus: challenges in management during infancy. Journal of Pediatric Endocrinology & Metabolism . 2014;27(1-2):193–197. doi: 10.1515/jpem-2013-0097. - DOI - PubMed

Publication types